Medicare Enrolled
Dr. Tabassum Hanif, MD
Pulmonary Disease · Palos Park, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hanif from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hanif?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hanif
Dr. Tabassum Hanif is a pulmonary disease specialist in Palos Park, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hanif performed 2,036 Medicare services across 1,122 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hanif received a total of $5,234 from 36 pharmaceutical and/or device companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hanif is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 20% volume in IL
$5,234 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,036
Medicare services
Top 20% in IL for pulmonary disease
1,122
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~102 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
785 | $98 | $549 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
335 | $180 | $1,026 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
191 | $96 | $286 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
119 | $139 | $385 |
| Annual depression screening | 109 | $19 | $48 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
92 | $26 | $87 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
88 | $44 | $174 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
67 | $34 | $111 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
65 | $20 | $88 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
57 | $141 | $538 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
28 | $32 | $195 |
| New patient office visit, complex (60-74 min) | 27 | $178 | $405 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
21 | $41 | $178 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
15 | $93 | $1,750 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
13 | $14 | $39 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
12 | $72 | $133 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
12 | $32 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,234
Total received (2018-2024)
Avg $748/year across 7 years
Top 30% in IL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
268
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,880 (93.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$354 (6.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$879
2023
$1,131
2022
$886
2021
$750
2020
$340
2019
$738
2018
$510
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
JAZZ PHARMACEUTICALS INC.
$273
GlaxoSmithKline, LLC.
$171
Avadel CNS Pharmaceuticals, LLC
$90
Mylan Specialty L.P.
$63
Boehringer Ingelheim Pharmaceuticals, Inc.
$58
HARMONY BIOSCIENCES LLC
$39
Insmed, Inc.
$37
Regeneron Healthcare Solutions, Inc.
$34
AstraZeneca Pharmaceuticals LP
$29
Grifols USA, LLC
$24
ABBVIE INC.
$23
Electromed, Inc.
$22
La Jolla Pharmaceutical Company
$15
Top 3 companies account for 60.9% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,304
JAZZ PHARMACEUTICALS INC.
$993
Boehringer Ingelheim Pharmaceuticals, Inc.
$428
Harmony Biosciences LLC
$383
Genentech USA, Inc.
$244
AstraZeneca Pharmaceuticals LP
$209
Regeneron Healthcare Solutions, Inc.
$172
Mylan Specialty L.P.
$163
HARMONY BIOSCIENCES LLC
$155
Pulmonx Corporation
$130
Grifols USA, LLC
$107
Avadel CNS Pharmaceuticals, LLC
$90
Sunovion Pharmaceuticals Inc.
$86
MERZ NORTH AMERICA, INC.
$86
Novartis Pharmaceuticals Corporation
$74
GENZYME CORPORATION
$64
Jazz Pharmaceuticals Inc.
$61
Insmed, Inc.
$57
Philips Electronics North America Corporation
$47
Electromed, Inc.
$43
Baxter Healthcare
$39
Merck Sharp & Dohme Corporation
$36
Advanced Respiratory, Inc
$29
Merck Sharp & Dohme LLC
$29
Takeda Pharmaceuticals U.S.A., Inc.
$23
ABBVIE INC.
$23
Amgen Inc.
$20
Janssen Pharmaceuticals, Inc
$18
Axsome Therapeutics, Inc.
$18
Vapotherm Inc
$17
La Jolla Pharmaceutical Company
$15
Melinta Therapeutics, Inc.
$15
Allergan Inc.
$15
Inspire Medical Systems, Inc.
$14
Inogen, Inc.
$14
Circassia Pharmaceuticals Inc
$11
Top 3 companies account for 52.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ANORO · ANORO ELLIPTA · Arikayce · BREO ELLIPTA · BREZTRI · BROVANA · CHARTIS CATHETER · DALVANCE · DIFICID · DUPIXENT · Dymista · Esbriet · FASENRA · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · NUCALA · OFEV · Perforomist · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · UTIBRON NEOHALER · Vabomere · WAKIX · Wakix · XARELTO · XEOMIN · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
241
Per 100K population
4.6
County median income
$81,797
Nearest hospital
PALOS COMMUNITY HOSPITAL
3.9 mi
3.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hanif is a clinical cardiology specialist, with above-average Medicare volume (top 20% in IL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hanif experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Hanif performed 785 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hanif receive payments from pharmaceutical companies?
Yes. Dr. Hanif received a total of $5,234 from 36 companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hanif's costs compare to other pulmonary diseases in Palos Park?
Dr. Hanif's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hanif) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Palos Park
Browse pulmonary diseases in Palos Park ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in IL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in IL
Which IL pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
JAZZ PHARMACEUTICALS INC. Payments to Doctors
See all physicians who received payments from JAZZ PHARMACEUTICALS INC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology